Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-002527

Chief Executive Officer acquired 62,815 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-28 Other acquisition : show line 1 in the form +62,815 62,815 I
Loading xslF345X05/rdgdoc.xml…